The diagnostic accuracy of the complete genome sequencing at the price of an NGS panel
The NGS Genomic Panel avoids the additional costs of step-by-step analysis of deletion / duplication, exome tracking or genome sequencing, mitochondrial analysis or analysis of new genes associated with the phenotype when new information emerges.
The next-generation sequencing panels (NGS) are a useful diagnostic tool when a patient's medical history suggests a clear genetic etiology. However, even when the correct genes are selected, there is still a 30-35% risk of a negative result *. To reduce the chances of an "inconclusive" result, the NGS panel tests can be combined with additional genetic tests. This increases the cost and time of diagnosis, and may still be missing in the relevant genomic region.
Significant price savings
Less expensive than complete genome sequencing.
Eliminates additional costs in step-by-step analysis such as Del / Dup, WES / WGS follow-up, mitochondrial analysis or analysis of new genes associated with the phenotype when new information emerges.
Reduced sequencing cost per region due to a lower coverage requirement.
Cost-effective for out-of-pocket payments and also for health care structures.